Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-21-052385

SVP & Chief Commercial Officer sold 6,192 shares at $13.83 ($85,635)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
NORTHCOTT JOHN SVP & Chief Commercial Officer 2021-08-16 Sale −6,192 $13.83 $85,635 200,915 D
Open-market sales · 6,192 sh · avg $13.83 · $85,635
Loading xslF345X03/doc4.xml…